314 related articles for article (PubMed ID: 27194756)
61. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.
Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM
Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472
[TBL] [Abstract][Full Text] [Related]
62. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
Cao X; Zhao B
Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
[TBL] [Abstract][Full Text] [Related]
63. Characterization of functional domains in the Merkel cell polyoma virus Large T antigen.
Houben R; Angermeyer S; Haferkamp S; Aue A; Goebeler M; Schrama D; Hesbacher S
Int J Cancer; 2015 Mar; 136(5):E290-300. PubMed ID: 25208506
[TBL] [Abstract][Full Text] [Related]
64. Identification of TAZ as a binding partner of the polyomavirus T antigens.
Tian Y; Li D; Dahl J; You J; Benjamin T
J Virol; 2004 Nov; 78(22):12657-64. PubMed ID: 15507652
[TBL] [Abstract][Full Text] [Related]
65. Differential effects of polyoma virus middle tumor antigen mutants upon gap junctional, intercellular communication.
Geletu M; Guy S; Greer S; Raptis L
Exp Cell Res; 2015 Aug; 336(2):223-31. PubMed ID: 26187405
[TBL] [Abstract][Full Text] [Related]
66. Catalytically inactive protein phosphatase 2A can bind to polyomavirus middle tumor antigen and support complex formation with pp60(c-src).
Ogris E; Mudrak I; Mak E; Gibson D; Pallas DC
J Virol; 1999 Sep; 73(9):7390-8. PubMed ID: 10438829
[TBL] [Abstract][Full Text] [Related]
67. Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner.
Jackson JB; Pallas DC
Neoplasia; 2012 Jul; 14(7):585-99. PubMed ID: 22904676
[TBL] [Abstract][Full Text] [Related]
68. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.
Yi X; Peterson J; Freund R
J Virol; 1997 Sep; 71(9):6279-86. PubMed ID: 9261344
[TBL] [Abstract][Full Text] [Related]
69. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).
Oka T; Mazack V; Sudol M
J Biol Chem; 2008 Oct; 283(41):27534-27546. PubMed ID: 18640976
[TBL] [Abstract][Full Text] [Related]
70. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
71. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.
Yang S; Zhang L; Liu M; Chong R; Ding SJ; Chen Y; Dong J
Cancer Res; 2013 Nov; 73(22):6722-33. PubMed ID: 24101154
[TBL] [Abstract][Full Text] [Related]
72. NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.
Garcia-Rendueles ME; Ricarte-Filho JC; Untch BR; Landa I; Knauf JA; Voza F; Smith VE; Ganly I; Taylor BS; Persaud Y; Oler G; Fang Y; Jhanwar SC; Viale A; Heguy A; Huberman KH; Giancotti F; Ghossein R; Fagin JA
Cancer Discov; 2015 Nov; 5(11):1178-93. PubMed ID: 26359368
[TBL] [Abstract][Full Text] [Related]
73. Phosphatase 2A associated with polyomavirus small-T or middle-T antigen is an okadaic acid-sensitive tyrosyl phosphatase.
Cayla X; Ballmer-Hofer K; Merlevede W; Goris J
Eur J Biochem; 1993 May; 214(1):281-6. PubMed ID: 8389702
[TBL] [Abstract][Full Text] [Related]
74. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
[TBL] [Abstract][Full Text] [Related]
75. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
76. Polyomavirus tumorantigens have a profound effect on gene expression in mouse fibroblasts.
Klucky B; Koch B; Radolf M; Steinlein P; Wintersberger E
Oncogene; 2004 Jun; 23(27):4707-21. PubMed ID: 15122341
[TBL] [Abstract][Full Text] [Related]
77. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
[TBL] [Abstract][Full Text] [Related]
78. Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells.
Ling LE; Druker BJ; Cantley LC; Roberts TM
J Virol; 1992 Mar; 66(3):1702-8. PubMed ID: 1371171
[TBL] [Abstract][Full Text] [Related]
79. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells.
Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y
J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824
[TBL] [Abstract][Full Text] [Related]
80. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
Jelinek MA; Hassell JA
Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
